Home Careers Contact Us Home About Us Products Responsibility Transfers of Value Our Partners News Events Transfers of Value “Within the framework of European level efforts to increase transparency, responsibility and credibility in the pharmaceutical industry, the pharmaceutical companies-members of KEFEA and EFPIA have taken the decision to disclose payments and other transfers of value to healthcare professionals (HCPs) and healthcare organisations (HCOs).” Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA) 2020 AstraZeneca Merck Papaloisou 2019 AstraZeneca Merck Papaloisou 2018 AstraZeneca Merck Papaloisou 2017 AstraZeneca Merck Papaloisou 2016 AstraZeneca Merck Recordati Papaloisou 2015 AstraZeneca Merck Recordati Papaloisou Copyright © 2020 C.G. Papaloisou Ltd Information & Adverse Event Reporting Privacy notice Disclaimer This website uses 'cookies' to give you the best, most relevant experience. Using this website means you’re OK with this. You can change which cookies are set at any time - and find out more about them in our cookie policy. More info. Accept

Home Careers Contact Us Home About Us Products Responsibility Transfers of Value Our Partners News Events Sales & marketing We market prescription medicines to doctors and other healthcare professionals, and to those who pay for healthcare. We focus on ensuring that the appropriate information is provided to those who need it to support the safe and effective use of our medicines. Adherence to a strict code of ethics when promoting our products to healthcare professionals is one of our top priorities. It is an important part of our commitment to patient health and safety and critical to maintaining trust in our company as a responsible business. We adhere to the latest Code of Conduct of the European Federation of Pharmaceutical Industries and Associations (EFPIA) as well as local industry bodies. Everyone at C.G.Papaloisou is required to be aware of, and conduct their activities in accordance with the codes and all the laws and regulations of Cyprus. Copyright © 2020 C.G. Papaloisou Ltd Information & Adverse Event Reporting Privacy notice Disclaimer This website uses 'cookies' to give you the best, most relevant experience. Using this website means you’re OK with this. You can change which cookies are set at any time - and find out more about them in our cookie policy. More info. Accept

Home Careers Contact Us Home About Us Products Responsibility Transfers of Value Our Partners News Events Introduction of Soolantra Cream Date: 06 May 2021 C.G. Papaloisou introduces a new product for the treatment of rosacea, Soolantra Cream. For more information about Soolantra Cream please click here. Copyright © 2020 C.G. Papaloisou Ltd Information & Adverse Event Reporting Privacy notice Disclaimer This website uses 'cookies' to give you the best, most relevant experience. Using this website means you’re OK with this. You can change which cookies are set at any time - and find out more about them in our cookie policy. More info. Accept